BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 61,600 shares, a drop of 16.4% from the April 30th total of 73,700 shares. Based on an average daily trading volume, of 1,140,000 shares, the short-interest ratio is currently 0.1 […]
Mesoblast (NASDAQ:MESO – Get Rating) and BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation. Risk & Volatility Mesoblast has a beta of 3.05, suggesting […]